Keyword: GlaxoSmithKline (GSK)
News
13.05.2015
- In an interview with the British business daily Financial Times (FT), Andrew Witty, CEO of Glaxo SmithKline (GSK), has questioned the economics of the current wave of mergers and...
Markets & Companies
13.03.2015
- Both European and US pharmaceutical industry players are highly research-oriented and possess very diversified portfolios. While each country has its national champions, Swiss...
News
05.03.2015
- Adaptimmune announced the appointments of Dr. Rafael Amado as Chief Medical Officer and Adrian (Ad) Rawcliffe as Chief Financial Officer, with effect of March 16, 2015. Dr. Amado...
News
27.02.2015
- The U.S. Federal Trade Commission has granted Novartis permission to acquire the GlaxoSmithKline (GSK) oncology portfolio - with some strings attached. Canada's competition...
News
16.02.2015
- GlaxoSmithKline (GSK), the UK's largest drugmaker, has acquired Swiss-based GlycoVaxyn, a privately held specialist vaccine biopharmaceutical producer, from Edmond de Rothschild...
News
30.01.2015
- The European Commission has approved a plan by Novartis and GlaxoSmithKline to swap assets worth more than $20 billion. The proposed deal dates back to April 2014, when Switzerland...
News
21.01.2015
- GlaxoSmithKline could consider more partial public share offerings for component units as it evolves in the coming years, potentially pointing to a break-up of the group if this...
News
01.12.2014
- Merck KGaA has no plans to divest its consumer health business, but rather intends to expand it, Uta Kemmerich-Keil, CEO of Merck Consumer Health, said at a media briefing in...
